City
Epaper

Maruti Suzuki goes digital, starts doorstep car delivery with new COVID-19 guidelines

By Lokmat English Desk | Updated: May 6, 2020 13:35 IST

Amidst the growing concerns of coronavirus cases in the country Maruti Suzuki India and Ford are now ready to ...

Open in App

Amidst the growing concerns of coronavirus cases in the country Maruti Suzuki India and Ford are now ready to offer home delivery of cars. Customers can choose the model, colour and accessories online and the car will be delivered at home.“All staff visiting the customer's home will follow safety protocols including wearing masks and carrying sanitizers. All cars will be fully disinfected before delivery. In case of delivery from showrooms, limited persons would be encouraged,” said the company’s statement. The company also said that this will be based on approvals from state governments, Maruti Suzuki dealerships have started to open and deliver the cars to customers in the waiting list.

Meanwhile, the company also issued a new guideline related to the COVID-19 pandemic to offer a safe, hygienic and a virus-free environment to customers at the time of delivery. All the dealership staff will wear hand gloves and masks when they are in the facility. Sanitisers will be kept at all dealerships for use. All the Maruti employees have been asked to download a specific health app. Their health will be monitored for 14 days through this app. It works in conjunction with the Aarogya Setu app recommended by the Indian government. On the other hand, test drive vehicles will be sanitised everyday. Only one person (driver) and the customer relationship manager can sit in the car during test drives. The relationship manager will be seated at the rear to maintain social distancing.     

Tags: CoronavirusMaruti Suzuki India
Open in App

Related Stories

TechnologyNew Covid Wave Could Peak by August-End in South Korea; Government Strengthens Response Measures

HealthCOVID-19: Only 2% of Patients Develop Autoantibodies After Recovery, Study Reveals

HealthAfter Covishield, BHU Study Reveals Side Effects of Covaxin; Including Hair Loss, Skin Issues, and Menstrual Irregularities

InternationalAstraZeneca Withdraws COVID-19 Vaccine Globally Days After Side Effect Row, Firm Says Decision ‘Commercial’

HealthGood News! Scientists Develop All-in-One Vaccine Effective Against Current and Future Coronavirus Variants

Business Realted Stories

BusinessSensex, Nifty open flat amid mixed global cues

BusinessNifty, Sensex opened flat before Fed meet, FPI inflows continue amid Indo-Pak tensions

BusinessRRBs should leverage lending in agriculture, MSME schemes: DFS Secretary

BusinessPrivate sector is interested in India's Nuclear Energy push, but policy gap remains: SBI

BusinessIndia's first Semiconductor Chip for D2M heralds leapfrog to next generation broadcasting